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Exserohilum rostratumwas the cause of most cases of fungal meningitis and other infections associated with the injection of
contaminated methylprednisolone acetate produced by the New England Compounding Center (NECC). Until this outbreak,
very few human cases of Exserohilum infection had been reported, and very little was known about this dematiaceous fungus,
which usually infects plants. Here, we report using whole-genome sequencing (WGS) for the detection of single nucleotide poly-
morphisms (SNPs) and phylogenetic analysis to investigate the molecular origin of the outbreak using 22 isolates of E. rostratum
retrieved from 19 case patients with meningitis or epidural/spinal abscesses, 6 isolates from contaminated NECC vials, and 7
isolates unrelated to the outbreak. Our analysis indicates that all 28 isolates associated with the outbreak had nearly identical
genomes of 33.8 Mb. A total of 8 SNPs were detected among the outbreak genomes, with nomore than 2 SNPs separating any 2 of
the 28 genomes. The outbreak genomes were separated from the next most closely related control strain by136,000 SNPs. We
also observed significant genomic variability among strains unrelated to the outbreak, which may suggest the possibility of cryp-
tic speciation in E. rostratum.
Beginning in September, 2012, the United States experienced oneof the largest outbreaks of health care-associated infections ever
reported. More than 13,000 people were exposed to three lots of con-
taminated methylprednisolone acetate (MPA) produced by a single
compounding pharmacy, and750 developed fungal infections fol-
lowing their MPA injections (1–3). Infections included meningitis, as
well as localized epidural, paraspinal, and peripheral joint infections,
complicated by arachnoiditis and abscess formation (4, 5). Although
several fungal species were implicated in the outbreak, the vast ma-
jority of infections were caused by Exserohilum rostratum, a sapro-
bic mold found in soil and plant debris worldwide (2, 6–10). Most
species of Exserohilum are plant pathogens. Exserohilum rostratum
and the species formerly known asExserohilum longirostratum and
Exserohilum mcginnisii are morphologically similar and are the
only species known to cause human infections; however, their
taxonomic status remains under investigation (11–13).
DNA fingerprinting has been used as an epidemiological tool
to answer questions pertaining to strain relatedness (14, 15).
However, no methodologies for DNA fingerprinting of E. rostra-
tum existed at the time of the outbreak. While whole-genome
sequencing (WGS) is a relatively new tool of molecular epidemi-
ology, it has quickly been embraced as a mechanism for inferring
phylogenetic relationships among organisms. This has translated
to the recent use of whole-genome single nucleotide polymor-
phism (SNP) typing (whole-genome sequence typing [WGST]) as
a mechanism for inferring relatedness of both bacteria (16–19)
and fungi (20, 21) during outbreak investigations. One of the ben-
efits of WGST is that prior knowledge of the genome is not neces-
sary to conduct epidemiologic analyses. The relationships be-
tween organisms are inferred from the number of SNPs: typically
the higher the number of SNPs in shared loci, the more distant the
relationship between organisms. While this can be confounded by
recombination, statistical bioinformatic analysis helps to discern
the nature of such events.
Here, we report the WGST and initial analysis of the whole-
genome sequence of E. rostratum. We use WGST to address two
important epidemiologic questions that arose during this out-
break investigation. First, separate lots of MPA, independently
compounded 42 days apart, were injected into patients and then
subsequently found to be contaminated with E. rostratum (8).
Were different lots of MPA contaminated with the same or differ-
ent fungal strains? Second, the CDC case-patient population was
classified into three groups: those with meningitis, those with lo-
calized epidural, paraspinal, or peripheral joint infections, and
those with both infections (8). Were the differences in clinical
manifestation due to different strains of E. rostratum? To answer
the epidemiologic questions posed above, the genomes of 22 E.
rostratum isolates from 19 case patients, 3 isolates from each of
two contaminated lots of MPA, and 7 unrelated control E. rostra-
tum isolates from the CDC collection were sequenced by WGS.
These data offer molecular insight into the epidemiology of the
outbreak and provide a foundation for subsequent comparative
genomic studies to identify the factors that are responsible for the
virulence of this pathogen in humans.
MATERIALS AND METHODS
Culture of isolates and preparation of DNA. Isolates of Exserohilum ro-
stratum (n 22) were submitted by state public health laboratories from
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cultures of specimens collected from 19 case patients who were exposed to
one of the implicated lots of preservative-free MPA produced by the New
England Compounding Center (NECC) after May 21, 2012 (22) and met
the CDC case definition as described previously (2) (Table 1). Patients
were from Virginia (3), Michigan (8), Tennessee (4), Maryland (1), and
Indiana (3). Specimens were cerebrospinal fluid (CSF) (16 specimens),
brain stem tissue (1 specimen), spinal/epidural abscess tissue (4 speci-
mens), and lumbar wound tissue (1 specimen). One isolate per patient
was submitted except in three cases where duplicate isolates from the same
CSF culture were submitted to the CDC, and each isolate was sequenced
separately.
Additional isolates (n 6) (Table 1) for identification were sent to the
CDC by the Food and Drug Administration (FDA). These isolates were
recovered from MPA vials from lots 06292012@26 and 08102012@51 that
were cultured by the FDA (2, 8). Since an Exserohilum isolate was never
recovered from lot 05212012@68, this lot was not included in this analysis.
TABLE 1 Sequenced E. rostratum strains
Isolate origin Lab no. Source of specimen
Date
specimen
collected
(mo/day/yr)
No. (lotc) of
injection(s)
received Origin of specimen
Depth coverage ()
GAII
(CDC)
HiSeq
(TGen)
MiSeq
(TGen)
PacBio
(CDC)
Patient 1_1a B9826 VAb 9/16/2012 1 (06) CSF 55 205
Patient 1_2 B9827 VA 9/16/2012 CSF 57 153
Patient 2_1a B9846 MI 9/21/2012 1 (06) CSF 74 ND
Patient 2_2 B9847 MI 9/21/2012 CSF 57 ND
Patient 3 B9823 TN 10/4/2012 2 (06) CSF 118 ND
Patient 4 B9824 MD 10/11/2012 Unk CSF 64 ND
Patient 5 B9860 MI 10/14/2012 6 (Unk) CSF 67 ND
Patient 6 B9831 IN 10/5/2012 1 (08) CSF 48 130
Patient 7 B9832 IN 10/5/2012 2 (1 08, 1 Unk) CSF 71 191
Patient 8 B9833 IN 10/5/2012 2 (1 05, 1 08) CSF 45 125
Patient 9 B9834 TN 10/4/2012 3 (2 06, 1 08) Brain stem 21 153
Patient 10 B9835 TN 10/2/2012 3 (2 06, 1 Unk) CSF 37 137
Patient 11 B9862 TN 10/18/2012 1 (08) CSF 61 123
Patient 12 B9839 VA 10/4/2012 2 (06) CSF 63 148
Patient 13_1a B9842 VA 10/4/2012 1 (06) CSF 45 144
Patient 13_2 B9843 VA 10/4/2012 CSF 77 129
Patient 14 B9845 MI 10/5/2012 1 (06) CSF 93 259
Patient 15 B9877 MI 11/8/2012 1 (06) Lumbar wound N/D 114
Patient 16 B9879 MI 11/8/2012 1 (06) Epidural abscess N/D 85
Patient 17 B9892 MI 10/31/2012 1 (06) Spinal abscess N/D 103
Patient 18 B9893 MI 11/6/2012 1 (06) Spinal abscess N/D 115
Patient 19 B9908 MI 11/30/2012 3 (2 06, 1 Unk) Spinal abscess N/D ND 32 91
Vial 1 B10011 Sample 744517 sub 3D 10/18/2012d NECC vial, MPA
06292012@26
59 143 28 131
Vial 2 B10016 Sample 756981 sub 7 10/18/2012 NECC vial, MPA
06292012@26
72 111
Vial 3 B9935 Sample 693965 sub 1-l 10/12/2012 NECC vial, MPA
08102012@51
86 131
Vial 4 B9970 Sample 693966 sub 3-I 10/12/2012 NECC vial, MPA
08102012@51
76 119
Vial 5 B9960 Sample 760871 sub 4 10/12/2012 NECC vial, MPA
08102012@51
79 119
Vial 6 B10014 Sample 756981 sub 12 10/18/2012 NECC vial, MPA
06292012@26
39 147
E. rostratum B6094 UTHSC 01-109 2001 Patient isolate, Texas 69 159
E. rostratum B6096 UTHSC 00-1435 2001 Patient isolate, Texas 62 106
E. rostratum B6171 2001 Environmental isolate,
Alabama
62 109
E. rostratum B6177 2001 Environmental isolate,
Alabama
88 135
E. rostratum B6207 2001 Environmental isolate,
Alabama
202 102
E. rostratume B6272 NCMH 1889 2002 Patient isolate, France (11) 50 122
E. rostratumf B6284 NCMH 2445, CBS 325.87 2002 Patient isolate, Arizona (11) 51 123
a Duplicate isolates from the same patient were obtained and analyzed.
b State in which the patient received MPA injection(s).
c 06 refers to MPA lot 06292012@26, 05 refers to MPA lot 05212012@68, 08 refers to MPA lot 08102012@51. Unk, lot injected is unknown.
d Date listed for vials is the date when the isolate from that vial was received at the CDC.
e Formerly E. longirostratum.
f Formerly E. mcginnisii.
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Seven unrelated E. rostratum isolates from the culture collection of the
Centers for Disease Control (CDC) were used as controls. Some of these
isolates were previously described (23). All isolates were identified to spe-
cies by microscopic examination and DNA sequencing as previously de-
scribed (8). The isolates were stored at70°C until used. The isolates were
cultured on Sabouraud dextrose agar, and DNA was extracted using a
Qiagen DNeasy blood and tissue kit (Qiagen, Gaithersburg, MD), follow-
ing the manufacturer’s recommendations.
DNA sequencing library preparation. The Illumina GAIIx and Pa-
cific Biosciences (PacBio) libraries were prepared at the CDC. For WGS
paired-end sequencing on the Illumina GAIIx DNA sequencer, genomic
DNAs were prepared using standard library construction protocols and
reagents from Illumina Inc. (San Diego, CA). Approximately 1g of DNA
was sheared using a Covaris S2 sonicator (Covaris Inc., Woburn, MA) to
a mean size of 350 bp. The DNA sequencing libraries were then prepared
using Illumina TruSeq chemistry and size selected using double AMPure
(Beckman Coulter) selection. Paired-end flow cells underwent cluster for-
mation using an Illumina cBot, followed by 100 100-bp cycle sequenc-
ing using SBS cycle sequencing V5 kits. The sequence data were processed
using CASAVA (v1.8.2) into paired FASTQ paired-end reads for down-
stream assembly and analysis.
For Pacific Biosciences sequencing, fungal genomic DNAs were
sheared to 10 kbp utilizing g-Tubes (Covaris Inc.). Sheared DNAs were
then used to generate large SMRTbell libraries with a Pacific Biosciences
(Menlo Park, CA) DNA template preparation kit using their standard
10-kb library protocol. Finished libraries were bound to a proprietary XL
polymerase and sequenced on a PacBio RS sequencer for 120-min movies
using C2 chemistry and V2 SMRT cells. Sequence reads were filtered and
assembled de novo utilizing the PacBio hierarchical genome assembly pro-
cess (HGAP1) or a modified Celera Assembler (PacBioToCA 2).
At the Translational Genomics Research Institute (TGen), additional
samples were prepared for paired-end sequencing using the Kapa Biosys-
tems (Woburn, MA) library preparation kit protocol with an 8-bp index
modification. One to 2g double-stranded DNA (dsDNA) was sheared to
an average size of 600 bp using SonicMan (Brooks Automation, Spokane,
WA), which was then prepared using the Kapa Illumina paired-end li-
brary preparation protocol as described by the manufacturer. Modified
oligonucleotides (Integrated DNA Technologies, Coralville, IA) with 8-bp
indexing capability (24) were substituted at the appropriate step. Prior to
sequencing, the libraries were quantified with quantitative PCR (qPCR)
on an ABI 7900HT system (Life Technologies Corporation, Carlsbad, CA)
using the Kapa Library quantification kit.
Parallel sequencing and data analysis. In order to ensure accurate
sequencing and SNP detection, 25 of 35 samples were sequenced in two
separate laboratories (CDC Biotechnology Core Facility and TGen, Flag-
staff, AZ) using different sequencing platforms and analyzed using mul-
tiple bioinformatic methods.
Twenty-five of the CDC-prepared libraries were sequenced both at the
CDC using the Illumina GAIIx platform and at TGen using the Illumina
HiSeq 2000 platform, following the recommendations of the manufac-
turer. Five libraries were sequenced only at CDC. Four libraries were
sequenced by TGen only using the Illumina HiSeq 2000 platform. Two
libraries were sequenced at TGen using the MiSeq platform; one of these
was also sequenced on the HiSeq platform. In addition, to improve assem-
bly metrics, the two MiSeq strains were also sequenced at the CDC using
the PacBio RSII platform (Table 1).
Read data from the 35 strains were deposited at the NCBI in the short-
read archive under BioProject accession number PRJNA245241.
Genomeassembly andSNPanalysis.Bioinformatic analysis and clus-
tering from the Illumina data at the CDC were conducted using a two-pass
approach. De novo assemblies of all isolates were performed using
Genomics Workbench 6.5 (CLC bio, Aarhus, Denmark) and assessed for
quality and assembly metrics. For de novo assembly, the following param-
eters were used: minimum contig length of 300 and similarity and length
fractions both 0.7. In the absence of an established reference sequence for
E. rostratum, an initial k-mer-based maximum likelihood tree was gener-
ated using kSNP (v2), with default parameters and a k-mer size of 25 bp
(25). This first-pass clustering was used to assess the overall diversity of
sample and comparator isolates and to determine suitable reference se-
quences for high-quality, alignment-mapped SNP analyses. The isolate
from patient 1_1 (B9826) was selected as an internal CDC reference se-
quence (Fig. 1), based on the assembly quality and the epidemiologic
context of the isolate (this strain was isolated from one of the first con-
firmed cases) (Table 1). Quality-checked and trimmed reads from all
other isolates were mapped to the concatenated reference sequence using
Genomics Workbench, and SNPs were called from the resulting align-
ments with a quality-based variant caller, using Phred quality thresholds
of Q20 (99%) at the central position and Q15 for five flanking bases (26).
The specific parameters for CLC bio reference mapping were: similarity,
0.7; length fraction, 0.7; insertion cost, 3; deletion cost, 3; mismatch cost,
2; global alignment, no; override paired distance, yes; and maximum dis-
tance, 400. Putative SNP calls for all strains were imported into a relational
database for postprocessing analyses. During postprocessing analysis, a
locus was added, if one among all the samples had a SNP with 100%
frequency and at least 25 coverage. For other samples, a minimum of
70% unbiased read-level consensus at 40 coverage was required. If a
sample did not meet either of these two criteria at that particular locus,
then that locus was not considered a SNP for that sample. A matrix of final
SNP alleles based on 1,239,535 variable positions for each isolate was
exported for WGST analysis.
FIG 1 Genetic relationships among 28 outbreak-related and 7 control strains
inferred using the neighbor-joining method based on 1,239,535 variable SNP
positions. The optimal tree with the branch length sum of 3.75039049 is drawn
to scale and rooted at midpoint, with branch lengths in the same units as those
of the evolutionary distances used to infer the phylogenetic tree. Gaps and
missing data are excluded. Numbers above the branches show bootstrap values
based on 500 replicates. A phylogenetic tree with the identical topology was
obtained using MP analysis (data not shown).
Litvintseva et al.
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TGen utilized a reference-based method in which all sequences were
compared against an assembled genome of a single isolate. For prelimi-
nary phylogenetic analyses, since no Exserohilum reference genomes were
previously published, TGen assembled B9908 (patient 19) from 250-bp
paired-end reads that were obtained on the Illumina MiSeq sequencer.
Specifically, FLASH was used to match overlapping MiSeq pairs using the
default parameters of the program and the following setting: min-over-
lap 25 (27). MIRA was used to generate an assembly from the overlap-
ping and unmerged pairs using the following settings: job genome, de
novo, accurate (28). Any contigs that were500 bp in length and/or were
assembled with less than two-thirds of the average coverage were removed
from the assembly.
For the final WGST analysis, TGen utilized the reference generated by
the CDC from B9826 (patient 1_1) for the kSNP analyses to ensure con-
sistency. The paired reads corresponding to all of the isolates were aligned
to the reference genome using the commercially available aligner, No-
voalign (Novocraft). Thereafter, the alignment file was processed using
the Genome Analysis Toolkit to identify all callable loci. Any position
that was not present at a minimum of 10 reads and/or was at a propor-
tion of90% of all bases at that position was removed prior to down-
stream analysis. The positions passing these filters were assigned as
references or variants. Duplicated regions were identified by a self-
comparison of the reference genome using MUMmer (v3.22) (29), and
calls within these repetitive regions were removed. A matrix was as-
sembled for positions in which all isolates at that loci contained a
confident call and at least one of the positions was a variant. This final
matrix was used for inferring phylogenetic relationships using the
maximum parsimony (MP) and neighbor-joining (NJ) methods in
molecular evolutionary genetic analysis (MEGA) (30). Gaps and miss-
ing data were excluded. Bootstrap values for the NJ phylogenetic tree
were obtained using 500 replications.
Discrepant SNP analysis. Because SNP calling took place at two sep-
arate institutions using different methodologies, discrepant SNPs were
independently verified by Sanger DNA sequencing. The targeted oligonu-
cleotide primers were designed upstream and downstream of each tar-
geted SNP so that the final amplicon size was approximately 500 nucleo-
tides with the targeted SNP roughly in the middle, and resultant
amplicons were sequenced using Sanger methodology (20).
Ploidy analysis. The alignment sequence read depths of the coverage
of the reference genome Illumina sequence data were compared across the
assembled contigs to detect possible aneuploidy. Genome ploidy was ex-
amined by comparing the variant allele frequencies across the assembled
genome (31).
RESULTS
The average sequencing depth obtained for the outbreak strains
was 135, which provided 99.9% coverage across the genomes
(Table 1). The preferred assembly of the outbreak strains using
MiSeq data produced 256 contigs with N50 (32) of 256,382 bp and
the draft genome size of 33.8 Mb (Table 2). Since only HiSeq and
GAII data were available for the control strains, on average 91% of
the genomes of the control strains were sequenced at a depth of
10, resulting in 1,124 contigs with N50 of 110,956 bp and the
draft genome size of 35.5 Mb (Table 2). The comparative depth of
coverage and the variant allele frequency across the assembled
contigs provided no evidence of aneuploidy (fold coverage varia-
tion across contigs) or polyploidy (variant allele frequencies other
than 0.9 or near zero), indicating that the outbreak genome is
likely haploid.
Sequencing and SNP analysis of reads from both the Illumina
and PacBio instruments produced nearly identical results. Within
the set of isolates associated with the outbreak, only seven non-
parsimonious concordant SNPs were identified. An additional
SNP identified by the Illumina but not the PacBio sequencing was
subsequently confirmed by the Sanger sequencing, for a total of
eight SNPs detected among the 28 outbreak strains, from 33.8
million bases in the genome. Conversely, the comparison between
the outbreak and unrelated control strains identified 1.2 million
SNPs, and the genome of the closest unrelated control B6272 was
differentiated from the genomes of the outbreak strains by
136,000 SNPs (Fig. 1).
The WGST analysis showed that most outbreak isolates had
identical genomes, with no more than two SNPs separating any 2
genomes. Specifically, 19 genomes were identical, representing
strains from CSF and abscess tissue specimens from patients in
Indiana, Michigan, Tennessee, and Virginia as well as the
06292012@26 and 08102012@51 MPA vials (patients 1_2, 2 to 6,
9, 11 to 13, 15, 16, 18, and 19 and vials 1, 2, and 5); eight strains had
single nonparsimonious SNPs (patients 1_1, 7, 8, 10, 14, and 17
and vials 4 and 6), and one strain from vial 3 had two nonparsi-
monious SNPs. There was a single SNP difference between the
genomes of two duplicate strains from patient 1, while genomes of
two other sets of duplicate strains were identical. Conversely,
20,043 SNPs were identified when we compared the two most
closely related control strains, B6177 and B6171, collected from an
outbreak in Alabama (Fig. 1). No differences in the genomes were
found when we compared the two lots of MPA, the geographic
location of the patient, or the syndrome of the patient.
DISCUSSION
To investigate the relatedness of E. rostratum strains associated
with the outbreak, we sequenced the genomes of 22 isolates from
19 case patients, 6 isolates from contaminated vials of MPA, and 7
isolates of E. rostratum unrelated to this outbreak. To ensure the
accuracy of SNP detection, isolates were sequenced at two differ-
ent laboratories using four different platforms and multiple com-
parative tools. The resulting data were analyzed separately and in
combination, resulting in  100 sequencing depth for most of
the strains and 99.9% coverage for the 33.8-Mb genome. Only
eight individual nonparsimonious SNPs were identified among
the 28 strains associated with the outbreak, and no more than two
SNPs differentiated any pair of strains isolated from the case pa-
tients and NECC vials. Conversely, approximately 1.2 million
SNPs were observed among the comparative isolate genomes not
linked to the outbreak. The most closely related control E. rostra-
tum isolate, B6272 (formerly E. longirostratum), differed from the
outbreak cluster by approximately 136,000 SNPs, suggesting di-
vergence between the outbreak and other available E. rostratum
strains. Overall, genetic diversity among the control strains of E.
rostratum was comparable to diversities observed in other groups
of fungi with sequenced genomes. For example, approximately
300,000 fixed SNPs were observed between Coccidioides immitis
and Coccidioides posadasii genomes (33), approximately 135,000
SNPs were identified among wild-type isolates of Neurospora
crassa from geographically different populations (34), and ap-
TABLE 2 Summary statistics for reference assemblies
Strain Origin
No. of
contigs
Total length
(Mb) N50
GC content
(%)
B6177 Control 1,121 35.5 110,956 50.8
Patient 19 Outbreak 256 33.8 256,382 51.1
Genome of Exserohilum rostratum
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proximately 28,000 SNPs were identified among strains of
Apophysomyces trapeziformis (21).
Overall, our data demonstrate that the outbreak strains are
highly clonal and strongly suggest their origination from a single
common source. Furthermore, isolates from the two different lots
of MPA were also indistinguishable from each other and from the
isolates from the case patients, suggesting that the source of the
contamination was persistent. However, the extent of diversity in
the natural population of E. rostratum in New England requires
further evaluation.
The most significant limitation of this study is that we did not
have any environmental or unrelated patient isolates of E. rostra-
tum from the same geographic area and/or from a time frame
similar to that of the MPA-associated isolates. Only a limited
number of E. rostratum strains were available in culture collec-
tions, and to our knowledge, all of them were isolated from spec-
imens from the southern United States or other countries. The
population genetics of E. rostratum is completely unknown at this
time, and the number of SNPs which can be expected between any
two strains in the United States was previously unknown. Our
preliminary results based on sequencing of seven isolates not re-
lated to the outbreak suggest that diversity is readily identifiable in
genome analysis of background isolates. Specifically, the two most
closely related strains, B6177 and B6171, both recovered from an
outbreak in Alabama (23), are separated from each other by
20,043 SNPs, which is considerably higher than the 0 to 2 SNPs
separating any two of the outbreak strains. However, more data
are needed to assess the genetic diversity among other strains of E.
rostratum in the environment.
Our results may also suggest the possibility of cryptic specia-
tion in E. rostratum; however, more research is necessary to inves-
tigate the genetic relationships among different clades. Phyloge-
netic analysis using WGS indicates three genetically distinct
groups, which are separated by hundreds of thousands of SNPs,
and may possibly represent distinct species. Group I includes all of
the outbreak strains as well as B6272 and B6094, group II includes
a single isolate B6284, and group III includes four isolates from
Texas and Alabama (Fig. 1). Notably, all control isolates were
morphologically indistinguishable from one another and had
identical internal transcribed spacer 1 (ITS1) and ITS2 ribosomal
DNA (rDNA) sequences (data not shown), suggesting that rDNA
sequences and morphology are not sufficient for differentiating
the distinct Exserohilum subpopulations identified here. Along
this line, we note that B6272, the isolate separated from the out-
break cluster by136,000 SNPs, was originally identified as Exse-
rohilum longirostratum (11), and we previously reported that the
outbreak isolates had conidia with 6 to 12 septa, somewhat resem-
bling the conidia of E. longirostratum (8). This species was later
placed into conspecificity with E. rostratum on the basis of multi-
locus sequence analysis (35). A further phylogenetic study of these
organisms at the whole-genome level as well as detailed morpho-
logical and physiological analyses of different genetic groups will
be needed to determine potential species boundaries. The genome
of another closely related species, Exserohilum turcicum, has re-
cently been released (36), but the genome size difference alone (43
Mb versus 33.8 Mb) shows just how much diversity lies within this
group of organisms and indicates that more research in needed to
understand the phylogeny of Exserohilum.
This study confirmed the utility of WGST for the epidemio-
logic investigation of fungal infections caused by species with no
previously established typing system. This is especially important
for outbreaks of fungal infections where rapid laboratory methods
to establish the relatedness of different strains may be the critical
factor in determining whether a cluster of rare mold infections
represent a true outbreak or a just an unusual coincidence. In the
past 18 months, the CDC has investigated several potential out-
breaks of rare molds that did not have established DNA typing
methods, including an outbreak of Bipolaris hawaiiensis associ-
ated with compounded triamcinolone for intraocular administra-
tion (37), Curvularia (Bipolaris) spicifera in cardiac surgical site
infections (CDC unpublished data), and Apophysomyces trapezi-
formis soft tissue infections occurring after a natural disaster (21).
The determination of whether these isolates were related relied on
painstaking epidemiologic studies, as typing methods were not
initially available.
Importantly, our data demonstrate that in mold outbreaks in-
volving contaminated medications, a high degree of clonality may
be expected. This is in contrast to outbreaks due to construction or
local factors, where a lower degree of relatedness may occur. These
findings will be important for investigators during future out-
breaks involving molds and highlight the importance of WGS in
these settings.
Similarly, WGS might also be a powerful tool in the investiga-
tion of potentially donor-derived transplant-related fungal infec-
tions. We earlier used WGS to investigate the etiology of three
Coccidioides immitis isolates recovered from organ recipients after
transplant, when transmission from a common organ donor was
suspected but no isolate was recovered from the donor (20). Be-
cause of the ubiquitous nature of many fungi in the environment,
it is often difficult, even when a donor and a recipient have the
same culture-positive fungal infection, to determine with cer-
tainty that it was transmitted via organ transplant if no typing
system exists. Knowing if an infection is donor-derived is time
sensitive and has important implications for both the testing and
treatment of organ recipients as well as surveillance to understand
how often these infections occur. As medical science continues to
advance, the population of persons susceptible to fungal infec-
tions due to critical illness or immune defects will continue to
expand. With this expansion, we will likely see more clusters and
outbreaks of emerging fungal infections, many agents of which
lack existing typing methods, making it important that available
laboratory tools such as WGS be utilized to their full extent in
order to detect outbreaks quickly and to identify outbreak sources
when possible.
This study demonstrates the usefulness of WGS for epide-
miologic outbreak investigations and for investigations of fun-
gal species with no previously established typing system. The
importance of a culture collection of isolates for use as phylo-
genetic controls during an investigation is apparent. One of the
hallmarks of WGS is that the data can be archived and stored in
publicly accessible databases. As more fungal genomes become
available in the public domain, they will serve as reference ge-
nomes during other investigations, enabling faster and more ac-
curate genome assemblies and providing controls for population
genetic analysis. Here, the data confirmed that isolates from the
case patients could not be distinguished from isolates from the
MPA vials, but were unrelated to E. rostratum isolates from an
archival collection.
Litvintseva et al.
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